53 results
Page 2 of 3
8-K
EX-99.1
87j2z46hj9ckjgpu58x
31 Mar 22
Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
5:13pm
S-3
fy1zaq9ii32
7 Feb 22
Shelf registration
9:33am
S-3
EX-1.2
2817 drjgcrfi1sul6a6
7 Feb 22
Shelf registration
9:33am
8-K
EX-99.1
a7pze s6ml97n1n2tl
15 Nov 21
Vivos Therapeutics Reports Third Quarter 2021 Financial Results
4:15pm
8-K
EX-99.1
0pjsj5
12 Aug 21
Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update
4:15pm
424B4
yu9d8su6oyyaj
19 May 21
Prospectus supplement with pricing info
5:30pm
8-K
EX-99.1
nnukppylg
17 May 21
Vivos Therapeutics Reports First Quarter 2021 Financial Results and Operational Update
4:15pm
10-Q
lirrns96ys2ycyu
17 May 21
Quarterly report
4:10pm
8-K
EX-1.1
fb626e1j w9pdi
12 May 21
Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
5:21pm
424B4
x0g zt4gfrvg
10 May 21
Prospectus supplement with pricing info
5:06pm
8-K
EX-99.1
7wbb3 n0xuel1aqjo4
25 Mar 21
Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
4:15pm
10-K
zy1f46ec7b4d
25 Mar 21
Annual report
4:15pm
8-K
EX-1.1
98k7l9tnk46lwpppf
15 Dec 20
Vivos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
5:05pm